$NVAX NOVAVAX INC Insider Trading Week 11/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NOVAVAX INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NOVAVAX INC in week 11/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 3.99 | 18,000 | 71,730 | 0 | |
| Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 46.00 | 4,500 | 207,000 | 0 | |
| Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | M | 99.80 | 2,000 | 199,600 | 0 | |
| Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 212.00 | 14,768 | 3,130,816 | 16,099 | 30.9 K to 16.1 K (-47.84 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Sell | S | 210.00 | 9,732 | 2,043,720 | 30,867 | 40.6 K to 30.9 K (-23.97 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 3.99 | 18,000 | 71,730 | 40,599 | 22.6 K to 40.6 K (+79.65 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 46.00 | 4,500 | 207,000 | 22,599 | 18.1 K to 22.6 K (+24.86 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | M | 99.80 | 2,000 | 199,600 | 18,099 | 16.1 K to 18.1 K (+12.42 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 5.95 | 4,819 | 28,673 | 56,462 | |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 5.95 | 3,124 | 18,588 | 68,752 | |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 46.00 | 1,101 | 50,646 | 16,322 | |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 27.60 | 868 | 23,957 | 6,605 | |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Option Exercise | M | 27.00 | 619 | 16,713 | 1,861 | |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 225.89 | 129 | 29,140 | 2,811 | 2.9 K to 2.8 K (-4.39 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 224.78 | 375 | 84,292 | 2,940 | 3.3 K to 2.9 K (-11.31 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 223.86 | 164 | 36,713 | 3,315 | 3.5 K to 3.3 K (-4.71 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 221.91 | 60 | 13,315 | 3,479 | 3.5 K to 3.5 K (-1.70 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 219.84 | 180 | 39,572 | 3,539 | 3.7 K to 3.5 K (-4.84 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 218.53 | 114 | 24,912 | 3,719 | 3.8 K to 3.7 K (-2.97 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 217.31 | 402 | 87,357 | 3,833 | 4.2 K to 3.8 K (-9.49 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 216.05 | 421 | 90,955 | 4,235 | 4.7 K to 4.2 K (-9.04 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 215.19 | 459 | 98,771 | 4,656 | 5.1 K to 4.7 K (-8.97 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 213.01 | 57 | 12,142 | 5,115 | 5.2 K to 5.1 K (-1.10 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 211.96 | 57 | 12,082 | 5,172 | 5.2 K to 5.2 K (-1.09 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 210.85 | 5 | 1,054 | 5,229 | 5.2 K to 5.2 K (-0.10 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Payment of Exercise | F | 217.46 | 2,264 | 492,329 | 5,234 | 7.5 K to 5.2 K (-30.19 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | D | 217.46 | 132 | 28,705 | 7,498 | 7.6 K to 7.5 K (-1.73 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 217.46 | 4,819 | 1,047,940 | 7,630 | 2.8 K to 7.6 K (+171.43 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 201.47 | 100 | 20,147 | 2,811 | 2.9 K to 2.8 K (-3.44 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 200.15 | 1,282 | 256,586 | 2,911 | 4.2 K to 2.9 K (-30.57 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 199.07 | 1,490 | 296,616 | 4,193 | 5.7 K to 4.2 K (-26.22 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 197.87 | 1,939 | 383,662 | 5,683 | 7.6 K to 5.7 K (-25.44 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Sell | S | 196.88 | 901 | 177,389 | 7,622 | 8.5 K to 7.6 K (-10.57 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 5.95 | 3,124 | 18,588 | 8,523 | 5.4 K to 8.5 K (+57.86 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 46.00 | 1,101 | 50,646 | 5,399 | 4.3 K to 5.4 K (+25.62 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 27.60 | 868 | 23,957 | 4,298 | 3.4 K to 4.3 K (+25.31 %) |
| Mar 17 2021 | NVAX | NOVAVAX INC | Glenn Gregory M | President, R&D | Buy | M | 27.00 | 619 | 16,713 | 3,430 | 2.8 K to 3.4 K (+22.02 %) |